Eckert & Ziegler SE/€EUZ
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Eckert & Ziegler SE
Eckert & Ziegler SE is a company operating in the pharmaceuticals industry, particularly specializing in the field of medical technology. It focuses on the development, production, and distribution of radioisotopes used for medical imaging, cancer treatment, and industrial applications. Some of its key products include low and high-energy sources used in brachytherapy and calibration sources for imaging devices. Founded in 1997, the company is headquartered in Berlin, Germany. Eckert & Ziegler SE leverages its technical expertise and regulatory experience to deliver specialized solutions, positioning itself as a critical provider in the healthcare and radiation therapy sectors.
Ticker
€EUZ
Sector
Primary listing
XETRA
Industry
Health Care Equipment & Supplies
Headquarters
Employees
1,094
ISIN
DE0005659700
Website
EUZ Metrics
BasicAdvanced
€1.4B
40.61
€1.63
1.58
€0.50
0.75%
Price and volume
Market cap
€1.4B
Beta
1.58
52-week high
€69.10
52-week low
€58.25
Average daily volume
21K
Dividend rate
€0.50
Financial strength
Current ratio
3.079
Quick ratio
2.395
Long term debt to equity
18.965
Total debt to equity
22.839
Dividend payout ratio (TTM)
3.02%
Interest coverage (TTM)
19.32%
Profitability
EBITDA (TTM)
78.819
Gross margin (TTM)
48.02%
Net profit margin (TTM)
11.63%
Operating margin (TTM)
22.94%
Effective tax rate (TTM)
30.65%
Revenue per employee (TTM)
€270,000
Management effectiveness
Return on assets (TTM)
9.36%
Return on equity (TTM)
17.64%
Valuation
Price to earnings (TTM)
40.61
Price to revenue (TTM)
4.665
Price to book
6
Price to tangible book (TTM)
7.61
Price to free cash flow (TTM)
26.502
Free cash flow yield (TTM)
3.77%
Free cash flow per share (TTM)
250.28%
Dividend yield (TTM)
0.75%
Forward dividend yield
0.75%
Growth
Revenue change (TTM)
15.89%
Earnings per share change (TTM)
13.18%
3-year revenue growth (CAGR)
16.77%
10-year revenue growth (CAGR)
8.56%
3-year earnings per share growth (CAGR)
7.83%
10-year earnings per share growth (CAGR)
15.96%
3-year dividend per share growth (CAGR)
-53.58%
10-year dividend per share growth (CAGR)
-10.40%
Bulls say / Bears say
Eckert & Ziegler SE reported a significant increase in sales and adjusted EBIT in 2024, indicating strong financial performance. (ezag.com)
The company achieved European approval for Theralugand® - Lutetium-177 Chloride (n.c.a), expanding its product portfolio in the radiopharmaceutical market. (marketscreener.com)
Analysts have a positive opinion on this stock, with an average consensus recommending overweighting or purchasing the stock. (marketscreener.com)
Eckert & Ziegler SE suffered a cyberattack in February 2025, which could impact operational efficiency and investor confidence. (marketscreener.com)
The company's high P/E ratio suggests that its stock may be overvalued compared to its earnings growth prospects. (simplywall.st)
Eckert & Ziegler SE pays small or no dividend to shareholders, making it less attractive to income-focused investors. (marketscreener.com)
Data summarised monthly by Lightyear AI. Last updated on 20 Jun 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Eckert & Ziegler SE stock?
Eckert & Ziegler SE (EUZ) has a market cap of €1.4B as of July 07, 2025.
What is the P/E ratio for Eckert & Ziegler SE stock?
The price to earnings (P/E) ratio for Eckert & Ziegler SE (EUZ) stock is 40.61 as of July 07, 2025.
Does Eckert & Ziegler SE stock pay dividends?
Yes, the Eckert & Ziegler SE (EUZ) stock pays dividends to shareholders. As of July 07, 2025, the dividend rate is €0.5 and the yield is 0.75%. Eckert & Ziegler SE has a payout ratio of 3.02% on a trailing twelve-month basis.
When is the next Eckert & Ziegler SE dividend payment date?
The next Eckert & Ziegler SE (EUZ) dividend payment date is unconfirmed.
What is the beta indicator for Eckert & Ziegler SE?
Eckert & Ziegler SE (EUZ) has a beta rating of 1.58. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.